THYROLAR-5
LOE ApproachingNDAORALTABLET
Approved
Nov 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
THYROLAR-5 is an oral tablet small molecule approved in 1969 for thyroid hormone replacement therapy. The specific indication and mechanism of action are not publicly detailed in available data, but the product name suggests thyroid-related therapeutic use. This is a legacy product with established clinical utility in endocrinology.
LOE Approaching
Product is approaching loss of exclusivity; commercial teams should expect declining headcount and transition focus to generic competition management or line extensions.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on THYROLAR-5 offers limited growth trajectory given LOE approaching status and zero linked job openings. Career value lies in defensive commercial strategy, generic competition management, and maintaining market presence in a stable but contracting therapeutic area. This role suits professionals seeking mature-market experience or end-of-life product management expertise.
Brand Manager
Worked on THYROLAR-5 at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.